Citation Impact
Citing Papers
Prognostic factors in metastatic prostate cancer
1993
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
Characterization of the Prostate-specific Antigen gene: A novel human kallikrein-like gene
1989
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.
1993
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
1991 Standout
Transrectal ultrasound in the diagnosis and staging of local disease after I125 seed implantation for prostate cancer
1988
Prostate Cancer
2003 StandoutNobel
Gene expression correlates of clinical prostate cancer behavior
2002 Standout
Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate
1994
Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses
1990
Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer
1994
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Prostatic Specific Antigen
1994
Daily variability in human serum prostate-specific antigen and prosttic acid phosphatase: A comparative evaluation
1988
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
2006 Standout
Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic Cancer
1987
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. I. Untreated Patients
1989
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 Standout
The Value of Serum Prostate Specific Antigen Determinations Before and after Radical Prostatectomy
1989
The Role of Prostate Specific Antigen as a Tumor Marker in Men with Advanced Adenocarcinoma of the Prostate
1989
Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
1989
Differences in Values Obtained with 2 Assays of Prostate Specific Antigen
1988
Prostate-Specific Antigenic Domain of Human Prostate Specific Antigen Identified with Monoclonal Antibodies
1989
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
The Influence of Reversible Androgen Deprivation on Serum Prostate-Specific Antigen Levels in Men with Benign Prostatic Hyperplasia
1989
Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
1991 Standout
Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice
2001 StandoutNobel
Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy
1988
Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?
1991
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.
1987
Tumour Markers in Prostatic Carcinoma. A Comparison of Prostate‐specific Antigen with Acid Phosphatase
1987
Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer
1994 Standout
Evaluation of prostate-specific antigen and prosttic acid phosphatase as prostate cancer markers
1986
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
1993
What's new in tumor markers for prostate cancer?
1986
A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
1991 Standout
Consensus statement: Guidelines for PSA following radiation therapy1
1997 Standout
Immunological characterization of human acid phosphatase gene products
1985
Works of Na Yang being referenced
Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer.
1985
Immunochemical evaluation of the organ specificity of prostatic acid phosphatase.
1981